{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:26:03Z","timestamp":1793931963183,"version":"4.8.0"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010485","name":"Japan Student Services Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006559","name":"University of Tsukuba","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006559","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT095831"],"award-info":[{"award-number":["WT095831"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005627","name":"Thrasher Research Fund","doi-asserted-by":"publisher","award":["9150"],"award-info":[{"award-number":["9150"]}],"id":[{"id":"10.13039\/100005627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT082028MA"],"award-info":[{"award-number":["WT082028MA"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research (NIHR) Global Health Research programme","award":["16\/136\/33"],"award-info":[{"award-number":["16\/136\/33"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The antihelminthic drug praziquantel has been used as the drug of choice for treating schistosome infection for more than 40 years. Although some epidemiological studies have reported low praziquantel efficacy in cure rate (CR) and\/or egg reduction rate (ERR), there is no consistent robust evidence of the development of schistosome resistance to praziquantel (PZQ). There is need to determine factors that lead to variable treatment CR and\/or ERR. Therefore, we conducted a systematic review and meta-analysis to review CR and ERR as well as identify their predictors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methodology\/Principal findings<\/jats:title>\n                    <jats:p>In this systematic review and meta-analysis, a literature review was conducted using Biosis Citation Index, Data Citation Index, MEDLINE, and Web of Science Core Collection all of which were provided through Web of Science. Alongside these, EMBASE, and CAB abstracts were searched to identify relevant articles. Random effect meta-regression models were used to identify the factors that influence CR and\/or ERR by considering differences in host characteristics and drug dose. In total, 12,127 potential articles were screened and 146 eligible articles (published from 1979 to 2020) were identified and included for the meta-analysis. We found that there has been no significant reduction in CR or ERR over the study period. The results showed more variability in CR, compared with ERR which was more consistent and remained high. The results showed a positive effect of \u201cPZQ treatment dose\u201d with the current recommended dose of 40 mg\/kg body weight achieving 57% to 88% CR depending on schistosome species, age of participants, and number of parasitological samples used for diagnosis, and ERR of 95%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions\/Significance<\/jats:title>\n                    <jats:p>Based on a review of over 40 years of research there is no evidence to support concerns about schistosomes developing resistance to PZQ. These results indicate that PZQ remains effective in treating schistosomiasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0009189","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T13:38:25Z","timestamp":1615988305000},"page":"e0009189","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":68,"title":["Efficacy of praziquantel has been maintained over four decades (from 1977 to 2018): A systematic review and meta-analysis of factors influence its efficacy"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3910-5574","authenticated-orcid":true,"given":"Mizuho","family":"Fukushige","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4668-333X","authenticated-orcid":true,"given":"Margo","family":"Chase-Topping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3765-8167","authenticated-orcid":true,"given":"Mark E. J.","family":"Woolhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Mutapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"issue":"2","key":"pntd.0009189.ref001","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00389899","article-title":"Praziquantel, a new board-spectrum antischistosomal agent","volume":"52","author":"R G\u00f6nnert","year":"1977","journal-title":"Z Parasitenkd"},{"issue":"7","key":"pntd.0009189.ref002","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ijpara.2005.02.005","article-title":"Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt","volume":"35","author":"S Botros","year":"2005","journal-title":"Int J Parasitol"},{"issue":"6","key":"pntd.0009189.ref003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008388","article-title":"Six rounds of annual praziquantel treatment during a national helminth control program significantly reduced schistosome infection and morbidity levels in a cohort of schoolchildren in Zimbabwe","volume":"14","author":"T Mduluza","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"pntd.0009189.ref004","first-page":"CD000528","article-title":"Drugs for treating Schistosoma mansoni infection","volume":"28","author":"A Danso-Appiah","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"pntd.0009189.ref005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1756-3305-4-201","article-title":"Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis","volume":"4","author":"R Liu","year":"2011","journal-title":"Parasit Vectors"},{"issue":"1","key":"pntd.0009189.ref006","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40249-018-0448-x","article-title":"Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomiasis in sub-Saharan Africa: a systematic review","volume":"7","author":"M Kabuyaya","year":"2018","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"pntd.0009189.ref007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13071-016-1958-7","article-title":"Efficacy and safety of praziquantel 40 mg\/kg in preschool-aged and school-aged children: a meta-analysis.","volume":"10","author":"J Zwang","year":"2017","journal-title":"Parasit Vectors"},{"issue":"5","key":"pntd.0009189.ref008","doi-asserted-by":"crossref","first-page":"902","DOI":"10.4269\/ajtmh.1974.23.902","article-title":"Schistosomiasis mansoni in Yemeni in California: duration of infection, presence of disease, therapeutic management","volume":"23","author":"KS Warren","year":"1974","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"pntd.0009189.ref009","first-page":"643","article-title":"Developmental bilharziasis caused by Schistosoma mansoni discovered 37 years after infestation","volume":"78","author":"D Chabasse","year":"1985","journal-title":"Bull Soc Pathol Exot Filiales"},{"issue":"9936","key":"pntd.0009189.ref010","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"DG Colley","year":"2014","journal-title":"Lancet"},{"issue":"12","key":"pntd.0009189.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002596","article-title":"Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections","volume":"7","author":"R Coeli","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"pntd.0009189.ref012","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijpara.2016.03.006","article-title":"Independent origins of loss-of-function mutations conferring oxamniquine resistance in a Brazilian schistosome population","volume":"46","author":"FD Chevalier","year":"2016","journal-title":"Int J Parasitol"},{"issue":"4","key":"pntd.0009189.ref013","doi-asserted-by":"crossref","first-page":"e0123673","DOI":"10.1371\/journal.pone.0123673","article-title":"Uptake of mass drug administration programme for schistosomiasis control in Koome Islands, Central Uganda","volume":"10","author":"D Tuhebwe","year":"2015","journal-title":"PLoS One"},{"key":"pntd.0009189.ref014","unstructured":"WHO. Number of MDA rounds for Schistosomiasis (Therapeutic Coverage-SAC), Africa Continent (2013\u20132018), Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) 2020 [updated 29 Sep. 2020. Available from: https:\/\/espen.afro.who.int\/."},{"issue":"4","key":"pntd.0009189.ref015","doi-asserted-by":"crossref","first-page":"951","DOI":"10.4269\/ajtmh.2010.10-0283","article-title":"Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania","volume":"83","author":"AJ Norton","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"pntd.0009189.ref016","doi-asserted-by":"crossref","first-page":"e1143","DOI":"10.1371\/journal.pntd.0001143","article-title":"Schistosoma haematobium treatment in 1\u20135 year old children: safety and efficacy of the antihelminthic drug praziquantel","volume":"5","author":"F Mutapi","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"pntd.0009189.ref017","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4269\/ajtmh.2004.71.778","article-title":"Efficacy of praziquantel against Schistosoma haematobium infection in children","volume":"71","author":"LA Tchuente","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"pntd.0009189.ref018","doi-asserted-by":"crossref","first-page":"e2975","DOI":"10.1371\/journal.pntd.0002975","article-title":"Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial","volume":"8","author":"J Keiser","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pntd.0009189.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002149","article-title":"Rapidly boosted plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils","volume":"7","author":"S Wilson","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009189.ref020","volume-title":"Assessing the efficacy of anthelminthic drugs against schistosomiasis and soil-transmitted helminthiases","author":"WHO","year":"2013"},{"issue":"7","key":"pntd.0009189.ref021","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1586\/14787210.2013.811931","article-title":"Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis","volume":"11","author":"JR Stothard","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"pntd.0009189.ref022","volume-title":"Prevention and control of schistosomiasis and soil-transmitted helminthiasis","author":"WHO","year":"2002"},{"key":"pntd.0009189.ref023","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/9780470743386.ch8","volume-title":"Factors that affect precision. Introduction to meta-analysis","author":"M Borenstein","year":"2009"},{"issue":"10","key":"pntd.0009189.ref024","doi-asserted-by":"crossref","first-page":"e0008650","DOI":"10.1371\/journal.pntd.0008650","article-title":"Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children","volume":"14","author":"RM Lim","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009189.ref025","unstructured":"WHO. Schistosomiasis control and preventive chemotherapy 2015 [cited 2020 May 25]. Available from: http:\/\/www.who.int\/schistosomiasis\/strategy\/en\/."},{"issue":"2","key":"pntd.0009189.ref026","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4269\/ajtmh.18-0067","article-title":"Schistosoma mansoni mass drug administration regimens and their effect on morbidity among schoolchildren over a 5-Year period-Kenya, 2010\u20132015","volume":"99","author":"AD Sircar","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pntd.0009189.ref027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/trstmh\/try095","article-title":"Egypt\u2019s schistosomiasis control programme in the 1980s prepared the ground for the global elimination of schistosomiasis by 2030","volume":"113","author":"A Fenwick","year":"2019","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"pntd.0009189.ref028","first-page":"13","article-title":"Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium","volume":"91","author":"P Taylor","year":"1988","journal-title":"J Trop Med Hyg"},{"issue":"6","key":"pntd.0009189.ref029","doi-asserted-by":"crossref","first-page":"e1165","DOI":"10.1371\/journal.pntd.0001165","article-title":"A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg\/kg vs. 60 mg\/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil","volume":"5","author":"PL Olliaro","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"pntd.0009189.ref030","doi-asserted-by":"crossref","first-page":"e3286","DOI":"10.1371\/journal.pntd.0003286","article-title":"Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials","volume":"8","author":"J Zwang","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0009189.ref031","first-page":"42","article-title":"Efficacity of praziquantel in school-aged children in a hyperendemic zone for Schistoma haematobium (Niger, 1999)","volume":"94","author":"A Garba","year":"2001","journal-title":"Bull Soc Pathol Exot"},{"issue":"13","key":"pntd.0009189.ref032","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1017\/S0031182008000486","article-title":"The effect of single dose versus two doses of praziquantel on Schistosoma haematobium infection and pathology among school-aged children in Mali","volume":"136","author":"M Sacko","year":"2009","journal-title":"Parasitology"},{"issue":"2","key":"pntd.0009189.ref033","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.actatropica.2013.06.007","article-title":"Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon","volume":"128","author":"LAT Tchuem","year":"2013","journal-title":"Acta Trop"},{"issue":"1","key":"pntd.0009189.ref034","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1179\/000349803125002553","article-title":"Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Cote d\u2019Ivoire","volume":"97","author":"EK N\u2019Goran","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"pntd.0009189.ref035","doi-asserted-by":"crossref","first-page":"e0005372","DOI":"10.1371\/journal.pntd.0005372","article-title":"Decline in infection-related morbidities following drug-mediated reductions in the intensity of Schistosoma infection: A systematic review and meta-analysis","volume":"11","author":"G Andrade","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"pntd.0009189.ref036","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/15169","article-title":"Seeking the ghost of worms past","volume":"5","author":"ME Woolhouse","year":"1999","journal-title":"Nat Med"},{"issue":"10","key":"pntd.0009189.ref037","doi-asserted-by":"crossref","first-page":"e1002237","DOI":"10.1371\/journal.pcbi.1002237","article-title":"Explaining observed infection and antibody age-profiles in populations with urogenital schistosomiasis","volume":"7","author":"KM Mitchell","year":"2011","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"pntd.0009189.ref038","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0035-9203(87)90360-9","article-title":"Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice","volume":"81","author":"MJ Doenhoff","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl","key":"pntd.0009189.ref039","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1017\/S003118200007534X","article-title":"Immune-dependent chemotherapy of schistosomiasis","volume":"105","author":"PG Fallon","year":"1992","journal-title":"Parasitology"},{"issue":"8","key":"pntd.0009189.ref040","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02253-17","article-title":"Pharmacokinetics of praziquantel in Schistosoma mansoni- and Schistosoma haematobium-infected school- and preschool-aged children","volume":"62","author":"J Kovac","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0009189.ref041","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2334-14-210","article-title":"Day-to-day fluctuation of point-of-care circulating cathodic antigen test scores and faecal egg counts in children infected with Schistosoma mansoni in Ethiopia","volume":"14","author":"A Degarege","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"2","key":"pntd.0009189.ref042","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1590\/0074-02760140375","article-title":"Evaluation of parasitological and molecular techniques for the diagnosis and assessment of cure of Schistosomiasis mansoni in a low transmission area","volume":"110","author":"LMV Siqueira","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"5","key":"pntd.0009189.ref043","doi-asserted-by":"crossref","first-page":"e0003752","DOI":"10.1371\/journal.pntd.0003752","article-title":"Sensitivity and specificity of a urine circulating anodic antigen test for the diagnosis of Schistosoma haematobium in low endemic settings","volume":"9","author":"S Knopp","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"pntd.0009189.ref044","doi-asserted-by":"crossref","first-page":"e0003821","DOI":"10.1371\/journal.pntd.0003821","article-title":"Toward measuring schistosoma response to praziquantel treatment with appropriate descriptors of egg excretion","volume":"9","author":"PL Olliaro","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"pntd.0009189.ref045","article-title":"Sensitivity and specificity of multiple kato-katz thick smears and a circulating cathodic antigen test for Schistosoma mansoni diagnosis pre- and post-repeated-praziquantel treatment","volume":"8","author":"PHL Lamberton","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0009189.ref046","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0035-9203(88)90282-9","article-title":"Cure rates and egg reduction in treatment of intestinal schistosomiasis with oxamniquine and praziquantel in Maniema, Zaire","volume":"82","author":"AM Polderman","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"pntd.0009189.ref047","first-page":"614","article-title":"Praziquantel efficacy and long-term appraisal of schistosomiasis control in Pemba Island","volume":"15","author":"A Guidi","year":"2010","journal-title":"Trop Med Int Health"},{"issue":"2","key":"pntd.0009189.ref048","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.actatropica.2012.09.010","article-title":"Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns","volume":"128","author":"BL Webster","year":"2013","journal-title":"Acta Trop"},{"issue":"13","key":"pntd.0009189.ref049","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ijpara.2005.05.002","article-title":"Effect of praziquantel on the immature stages of Schistosoma haematobium","volume":"35","author":"S Botros","year":"2005","journal-title":"Int J Parasitol"},{"issue":"4","key":"pntd.0009189.ref050","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijpara.2003.12.003","article-title":"Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment","volume":"34","author":"L Pica-Mattoccia","year":"2004","journal-title":"Int J Parasitol"},{"issue":"1","key":"pntd.0009189.ref051","first-page":"7","article-title":"Effectiveness of praziquantel against the South African strains of Schistosoma haematobium and S. mansoni","volume":"64","author":"CH Schutte","year":"1983","journal-title":"S Afr Med J"},{"issue":"1","key":"pntd.0009189.ref052","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0001-706X(90)90062-5","article-title":"Mixed Schistosoma haematobium and S. mansoni infection: effect of different treatments on the serum level of circulating anodic antigen (CAA)","volume":"48","author":"Jonge Nd","year":"1990","journal-title":"Acta Trop"},{"issue":"6","key":"pntd.0009189.ref053","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.4269\/ajtmh.2006.75.1034","article-title":"Spatial and temporal variations in local transmission of Schistosoma haematobium in Msambweni, Kenya","volume":"75","author":"JA Clennon","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pntd.0009189.ref054","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.actatropica.2007.09.006","article-title":"Micro-epidemiology of urinary schistosomiasis in Zanzibar: Local risk factors associated with distribution of infections among schoolchildren and relevance for control","volume":"105","author":"JW Rudge","year":"2008","journal-title":"Acta Trop"},{"issue":"9282","key":"pntd.0009189.ref055","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0140-6736(01)05796-8","article-title":"Counterfeit praziquantel","volume":"358","author":"SM Sulaiman","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"pntd.0009189.ref056","first-page":"208","article-title":"Quality assessment of praziquantel tablets sold in medicine stores in Kano Metropolis","volume":"11","author":"K.A. GMAA","year":"2018","journal-title":"BAJOPAS"},{"issue":"5","key":"pntd.0009189.ref057","doi-asserted-by":"crossref","first-page":"e1001640","DOI":"10.1371\/journal.pmed.1001640","article-title":"Effectiveness of a pre-treatment snack on the uptake of mass treatment for schistosomiasis in Uganda: A cluster randomized trial","volume":"11","author":"S Muhumuza","year":"2014","journal-title":"PLoS Med"},{"issue":"1","key":"pntd.0009189.ref058","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0001-706X(98)00084-9","article-title":"Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia","volume":"72","author":"N Berhe","year":"1999","journal-title":"Acta Trop"},{"issue":"2","key":"pntd.0009189.ref059","first-page":"215","article-title":"Effectiveness and tolerance of praziquantel in schistosomiasis","volume":"37","author":"E Groning","year":"1985","journal-title":"Rev Cubana Med Trop"},{"issue":"2","key":"pntd.0009189.ref060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.inhe.2010.02.003","article-title":"Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole","volume":"2","author":"JC Sousa-Figueiredo","year":"2010","journal-title":"Int Health"},{"issue":"10","key":"pntd.0009189.ref061","doi-asserted-by":"crossref","first-page":"e1864","DOI":"10.1371\/journal.pntd.0001864","article-title":"Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children","volume":"6","author":"JC Sousa-Figueiredo","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"pntd.0009189.ref062","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.trstmh.2012.03.013","article-title":"Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety","volume":"106","author":"AM Navaratnam","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"pntd.0009189.ref063","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.trstmh.2008.03.010","article-title":"Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe","volume":"102","author":"N Midzi","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"pntd.0009189.ref064","first-page":"532","article-title":"Intestinal schistosomiasis among children in a labor village of wonji sugar estate, Ethiopia","volume":"67","author":"PE Simonsen","year":"1990","journal-title":"East Afr Med J"},{"issue":"2","key":"pntd.0009189.ref065","first-page":"95","article-title":"Comparative study of oltipraz versus praziquantel for treatment of schistosomiasis with intestinal manifestation in the Gabon (Schistosoma intercalatum and S. haematobium)","volume":"35","author":"P Kern","year":"1984","journal-title":"Tropenmed Parasitol"},{"issue":"2","key":"pntd.0009189.ref066","first-page":"91","article-title":"Comparative trial of oltipraz versus praziquantel in the treatment of urinary schistosomiasis in the Gabon","volume":"35","author":"GD Burchard","year":"1984","journal-title":"Tropenmed Parasitol"},{"issue":"2","key":"pntd.0009189.ref067","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/infdis\/150.2.307","article-title":"Treatment of bilharzial obstructive uropathy with praziquantel","volume":"150","author":"L Farid","year":"1984","journal-title":"J Infect Dis"},{"issue":"9","key":"pntd.0009189.ref068","doi-asserted-by":"crossref","first-page":"e0008649","DOI":"10.1371\/journal.pntd.0008649","article-title":"Drug metabolism and pharmacokinetics of praziquantel: A review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models","volume":"14","author":"G Zdesenko","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pntd.0009189.ref069","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1017\/S0031182000059874","article-title":"Heterogeneities in water contact patterns and the epidemiology of Schistosoma haematobium","volume":"103","author":"SK Chandiwana","year":"1991","journal-title":"Parasitology"},{"issue":"6","key":"pntd.0009189.ref070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-3024.1997.d01-206.x","article-title":"A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection","volume":"19","author":"F Mutapi","year":"1997","journal-title":"Parasite Immunol"},{"issue":"2","key":"pntd.0009189.ref071","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1017\/S0031182000053956","article-title":"Immunity in human Schistosomiasis mansoni: prevention by blocking antibodies of the expression of immunity in young children","volume":"94","author":"AE Butterworth","year":"1987","journal-title":"Parasitology"},{"issue":"1","key":"pntd.0009189.ref072","article-title":"A call for systems epidemiology to tackle the complexity of schistosomiasis, its control, and its elimination","volume":"4","author":"SJ Krauth","year":"2019","journal-title":"Trop Med Infect Dis"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T13:39:25Z","timestamp":1615988365000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009189"}},"subtitle":[],"editor":[{"given":"Robert M.","family":"Greenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":72,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009189","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]}}}